• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体淀粉样β在阿尔茨海默病中的作用。

Role of mitochondrial amyloid-beta in Alzheimer's disease.

机构信息

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

J Alzheimers Dis. 2010;20 Suppl 2:S569-78. doi: 10.3233/JAD-2010-100357.

DOI:10.3233/JAD-2010-100357
PMID:20463403
Abstract

Mitochondrial dysfunction is an early feature of Alzheimer's disease (AD). Abnormalities in mitochondrial properties include impaired energy metabolism, defects in key respiratory enzyme activity/function, accumulation/generation of mitochondrial reactive oxygen species, and formation of membrane permeability transition pore. While the mechanisms underlying mitochondrial dysfunction remain incompletely understood, recent studies provide substantial evidence for the progressive accumulation of mitochondrial Abeta, which directly links to mitochondria-mediated toxicity. In this review, we describe recent studies addressing the following key questions: 1) Does Abeta accumulate in mitochondria of AD brain and AD mouse models? 2) How does Abeta gain access to the mitochondria? 3) If mitochondria are loaded with Abeta, do they develop similar evidence of dysfunction? 4) What are the mechanisms underlying mitochondrial Abeta-induced neuronal toxicity? and 5) What is the impact of interaction of mitochondrial Abeta with its binding partners (cyclophilin D and ABAD) on mitochondrial and neuronal properties/function in an Abeta milieu? The answers to these questions provide new insights into mechanisms of mitochondrial stress related to the pathogenesis of AD and information necessary for developing therapeutic strategy for AD.

摘要

线粒体功能障碍是阿尔茨海默病(AD)的早期特征。线粒体特性的异常包括能量代谢受损、关键呼吸酶活性/功能缺陷、线粒体活性氧物质的积累/产生以及膜通透性转换孔的形成。虽然线粒体功能障碍的机制尚不完全清楚,但最近的研究为线粒体中 Abeta 的进行性积累提供了大量证据,这与线粒体介导的毒性直接相关。在这篇综述中,我们描述了最近的研究,以回答以下关键问题:1)Abeta 是否在 AD 大脑和 AD 小鼠模型的线粒体中积累?2)Abeta 如何进入线粒体?3)如果线粒体中充满了 Abeta,它们是否会出现类似的功能障碍证据?4)线粒体 Abeta 诱导神经元毒性的机制是什么?以及 5)在 Abeta 环境中,线粒体 Abeta 与其结合伙伴(亲环素 D 和 ABAD)的相互作用对线粒体和神经元的特性/功能有什么影响?这些问题的答案为与 AD 发病机制相关的线粒体应激机制提供了新的见解,并为开发 AD 治疗策略提供了必要的信息。

相似文献

1
Role of mitochondrial amyloid-beta in Alzheimer's disease.线粒体淀粉样β在阿尔茨海默病中的作用。
J Alzheimers Dis. 2010;20 Suppl 2:S569-78. doi: 10.3233/JAD-2010-100357.
2
Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.线粒体淀粉样β水平与不同脑区线粒体功能障碍的程度以及阿尔茨海默病转基因小鼠认知障碍的严重程度相关。
J Alzheimers Dis. 2010;20 Suppl 2:S535-50. doi: 10.3233/JAD-2010-100342.
3
Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.线粒体β淀粉样蛋白:阿尔茨海默病代谢功能障碍的一个潜在原因。
IUBMB Life. 2006 Dec;58(12):686-94. doi: 10.1080/15216540601047767.
4
Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.线粒体β淀粉样肽的致病作用。 [“mitochondral”应为“mitochondrial”的修正]
Expert Rev Neurother. 2007 Nov;7(11):1517-25. doi: 10.1586/14737175.7.11.1517.
5
Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.淀粉样前体蛋白与阿尔茨海默病中的线粒体功能障碍
Neuroscientist. 2007 Dec;13(6):626-38. doi: 10.1177/1073858407303536. Epub 2007 Oct 2.
6
The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.阿尔茨海默病中线粒体淀粉样β肽的后果。
Biochem J. 2010 Feb 24;426(3):255-70. doi: 10.1042/BJ20091941.
7
A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.散发性阿尔茨海默病的“线粒体级联假说”
Med Hypotheses. 2004;63(1):8-20. doi: 10.1016/j.mehy.2003.12.045.
8
Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction.[Gly14]-脑心肽通过防止线粒体功能障碍对β-淀粉样肽诱导的 PC12 细胞死亡的保护作用。
Neurochem Int. 2010 Feb;56(3):417-23. doi: 10.1016/j.neuint.2009.11.015. Epub 2009 Nov 24.
9
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.阿尔茨海默病中β淀粉样蛋白介导神经退行性变的机制
Int J Biochem Cell Biol. 2008;40(2):181-98. doi: 10.1016/j.biocel.2007.07.013. Epub 2007 Aug 1.
10
Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.线粒体淀粉样前体蛋白:阿尔茨海默病中神经元代谢功能障碍的潜在焦点。
FASEB J. 2005 Dec;19(14):2040-1. doi: 10.1096/fj.05-3735fje. Epub 2005 Oct 6.

引用本文的文献

1
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
2
Innate and adaptive immunity in neurodegenerative disease.神经退行性疾病中的先天性免疫和适应性免疫。
Cell Mol Life Sci. 2025 Feb 2;82(1):68. doi: 10.1007/s00018-024-05533-4.
3
Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.
在阿尔茨海默病受累神经元中,淀粉样前体蛋白水解途径中β淀粉样蛋白的产生停止或受到严重抑制:对“显而易见”的观点提出质疑。
Genes (Basel). 2025 Jan 2;16(1):46. doi: 10.3390/genes16010046.
4
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration.电压依赖性阴离子通道1:神经退行性变线粒体格局中的关键角色。
Biomolecules. 2024 Dec 30;15(1):33. doi: 10.3390/biom15010033.
5
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases.CXCL12/CXCR4/CXCR7轴在与神经退行性疾病相关的认知障碍中的作用。
Brain Behav Immun Health. 2024 Dec 24;43:100932. doi: 10.1016/j.bbih.2024.100932. eCollection 2025 Feb.
6
Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds.膳食补充剂及植物化学物质在对抗阿尔茨海默病中的作用:聚焦于多酚类化合物。
J Prev Alzheimers Dis. 2025 Jan;12(1):100004. doi: 10.1016/j.tjpad.2024.100004. Epub 2025 Jan 1.
7
Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.精髓协同作用:同时给予综合应激反应抑制剂和 BACE1 和/或 BACE2 激活剂,作为阿尔茨海默病的最佳治疗策略。
Int J Mol Sci. 2024 Sep 13;25(18):9913. doi: 10.3390/ijms25189913.
8
The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer's disease.白细胞介素-1 家族细胞因子在阿尔茨海默病发病机制和治疗中的作用。
Inflammopharmacology. 2024 Oct;32(5):2681-2694. doi: 10.1007/s10787-024-01534-8. Epub 2024 Aug 10.
9
Unveiling the Complex Role of Exosomes in Alzheimer's Disease.揭示外泌体在阿尔茨海默病中的复杂作用。
J Inflamm Res. 2024 Jun 18;17:3921-3948. doi: 10.2147/JIR.S466821. eCollection 2024.
10
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.ACH2.0/E,即传统和非传统阿尔茨海默病的综合理论:起源、进展和治疗策略。
Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.